The finding that women with higher IL-6, PAP, D-dimer, and leukocyte counts at baseline were at lower risk for stroke if assigned to estrogen plus progestin than placebo, but not estrogen alone, is counterintuitive and is likely due to a noncausal association since both hormone treatment groups had similar stroke rates. This evidence concerns the gene IL6 and stroke disorder.